FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 336:138 January 9, 1997 Number 2 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

To the Editor: Ritonavir (Norvir, Abbott Laboratories), a protease inhibitor used to treat people with human immunodeficiency virus (HIV) infection, reportedly has no adverse effects on renal function.^1,2 We describe a patient in whom acute renal failure developed shortly after the start of treatment with ritonavir.

The patient was a 40-year-old man with HIV infection and stable chronic renal failure. His kidney disease was thought to be due to a horseshoe kidney and to glomerular disease of unknown cause, manifested by an episode of proteinuria in the nephrotic range and, more recently, by the excretion of 1 to 2 g . . . [Full Text of this Article]

References

This article has been cited by other articles:

• van Rossum, A. M. C., Dieleman, J. P., Fraaij, P. L. A., Cransberg, K., Hartwig, N. G., Burger, D. M., Gyssens, I. C., de Groot, R. (2002). Persistent Sterile Leukocyturia Is Associated With Impaired Renal Function in Human Immunodeficiency Virus Type 1-Infected Children Treated With Indinavir. Pediatrics 110: e19-19 [Abstract] [Full Text]  
• Herman, J. S., Ives, N. J., Nelson, M., Gazzard, B. G., Easterbrook, P. J. (2001). Incidence and risk factors for the development of indinavir-associated renal complications. J Antimicrob Chemother 48: 355-360 [Abstract] [Full Text]  
• Hanabusa, H., Tagami, H., Hataya, H. (1999). Renal Atrophy Associated with Long-Term Treatment with Indinavir. NEJM 340: 392-393 [Full Text]